CTLA4 and breast cancer: A recent study showed that anti-CTLA4 treatment in orthotopically implanted EO771 and spontaneous mouse mammary tumor virus (MMTV)-PyVT breast cancer murine models induced tumor vessel normalization and increased treatment efficacy, through eosinophil infiltration [39].